Alkermes Plc (NASDAQ:ALKS)
| 28.20 Delayed Data As of 4:00pm ET |  +0.38 / +1.37%Today’s Change | 21.75 Today|||52-Week Range 32.79 | +7.92% Year-to-Date |
Latest ALKS News | Press Releases
| Acadia (ACAD) Down 10.9% Since Last Earnings Report: Can It Rebound? Mar 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 27.82 |
| Today’s open | 27.75 |
| Day’s range | 27.74 - 28.27 |
| Volume | 29,754 |
| Average volume (3 months) | 1,290,042 |
| Market cap | $4.4B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -223.35% |
| Earnings growth (this year) | -62.74% |
| Earnings growth (next 5 years) | +41.43% |
| Revenue growth (last year) | -5.28% |
| P/E ratio | NM |
| Price/Sales | 3.84 |
| Price/Book | 4.17 |
Competitors
| ---- |
| ---- |
| ---- |
| ---- |
Data as of 12/30/1899
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$158.3M |
| Net profit margin | -14.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
